Analysis of multi-treatment experiments aims to optimize winner selection and effect estimation, suggesting improved methods over standard approaches.
We study the design of experiments with multiple treatment levels, a setting common in clinical trials and online A/B/n testing. Unlike single-treatment studies, practical analyses of multi-treatment experiments typically first select a winning treatment, and then only estimate the effect therein. Motivated by this analysis paradigm, we propose a design for MUlti-treatment experiments that jointly maximizes the accuracy of winner Selection and effect Estimation (MUSE). Explicitly, we introduce a single objective that balances selection and estimation, and determine the unit allocation to treatments and control by optimizing this objective. Theoretically, we establish finite-sample guarantees and asymptotic equivalence between our proposal and the Neyman allocation for the true optimal treatment and control. Across simulations and a real data application, our method performs favorably in both selection and estimation compared to various standard alternatives.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: